Clinical trial
Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients…
NCT00033436 · Mount Vernon Cancer Centre at Mount Vernon Hospital, Other · Completed
Key facts
| NCT number | NCT00033436 |
|---|---|
| Title | Radiation Therapy With or Without Carbogen and Niacinamide in Treating Patients With Bladder Cancer |
| Official title | A Multicenter Randomized Trial of Radical Radiotherapy With Carbogen in the Radical Treatment of Locally Advanced Bladder Cancer |
| Lead sponsor | Mount Vernon Cancer Centre at Mount Vernon Hospital, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bladder Cancer |
| Intervention type | Dietary Supplement, Drug, Radiation |
| Interventions | niacinamide, carbogen, radiation therapy |
| Enrollment | 330 |
| Start date | Oct 1, 2000 |
| Completion | Nov 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Sep 20, 2013 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: